Complement Pathways: Classical, Alternative & Lectin

The Complement Pathways are three interconnected mechanisms through which complement proteins become activated to support immune defence. These pathways are known as the classical pathway, alternative pathway, and lectin pathway. Although they differ in their initiating triggers and recognition mechanisms, all three contribute to the elimination of pathogens through inflammation, opsonization, and activation of the terminal complement pathway.

The classical pathway is commonly initiated when C1q recognizes antibodies bound to their target antigens. The alternative pathway relies on continuous low-level C3 activation and amplification on suitable microbial surfaces, while the lectin pathway begins when recognition molecules such as mannose-binding lectin (MBL) or ficolins bind to characteristic molecular patterns on microorganisms.

A central feature of the Complement Pathways is their convergence on the activation of complement component C3. Each pathway produces a C3 convertase, an enzyme complex that cleaves C3 into C3a and C3b. Subsequent reactions lead to C5 activation and may initiate the formation of the membrane attack complex (MAC), which damages susceptible microbial membranes.

The Complement Pathways is essential in immunology because it explains how different recognition mechanisms activate a coordinated immune response. It also helps clarify the roles of complement proteins, the importance of regulatory mechanisms, and the clinical consequences of complement deficiencies or excessive activation.

Overview of the Three Complement Pathways

The Complement Pathways are different routes of complement activation that help the immune system recognize and eliminate pathogens. Each pathway begins through a distinct recognition mechanism, but all three activate a coordinated cascade of enzymatic reactions that contributes to inflammation, opsonization, and microbial killing.

The three pathways are the classical pathway, the alternative pathway, and the lectin pathway.

1. Classical Pathway

The classical pathway is commonly activated when C1q recognizes antibodies bound to their target antigens. The antibodies most associated with this pathway are IgM and certain IgG subclasses.

The activated C1 complex initiates a sequence involving complement components C4 and C2. These components form the classical pathway C3 convertase, designated C4b2a, which cleaves C3 into C3a and C3b.

This pathway links antibody-mediated recognition with complement-mediated immune defence.

2. Alternative Pathway

The alternative pathway does not require antibodies for activation. It begins through continuous low-level C3 activation and is amplified when complement fragments become deposited on suitable microbial surfaces.

Complement component C3b binds Factor B, which is cleaved by Factor D. The resulting complex, C3bBb, functions as the alternative pathway C3 convertase. Properdin can stabilize this complex and support further complement activation.

The alternative pathway is especially important for innate immunity and for amplifying complement responses initiated through the other pathways.

3. Lectin Pathway

The lectin pathway begins when recognition molecules such as mannose-binding lectin (MBL) or ficolins bind to characteristic molecular patterns on microbial surfaces.

These recognition molecules are associated with MBL-associated serine proteases (MASPs), which initiate the cleavage of C4 and C2. The resulting C3 convertase is C4b2a, the same type formed by the classical pathway.

Unlike the classical pathway’s usual antibody-dependent initiation, the lectin pathway recognizes microbial molecular patterns without requiring antibodies.

Comparison of the Three Pathways

Despite their different initiation mechanisms, all three Complement Pathways generate C3 convertases and can proceed to C5 activation. Their downstream effects include:

• Opsonization of pathogens by C3b and related fragments.
• Inflammatory responses involving C3a and C5a.
• Recruitment and activation of immune cells, particularly through C5a.
• Formation of the membrane attack complex through the terminal complement components C5b–C9.

This shared cascade allows different forms of pathogen recognition to activate coordinated immune defence.

Classical Complement Pathway — Detailed Mechanism

The classical pathway is one of the major routes of complement activation. It connects antibody-mediated antigen recognition with the effector mechanisms of innate immunity. Although antibodies are the most familiar triggers, certain antibody-independent interactions can also activate this pathway.

The classical pathway proceeds through a series of enzymatic reactions involving the C1 complex, complement components C4 and C2, and the formation of C3 and C5 convertases. Understanding these steps explains how the Complement Pathways translate pathogen recognition into an amplified immune response.

1. Recognition by the C1 Complex

The pathway usually begins when C1q recognizes the Fc regions of appropriately arranged antibodies bound to antigens. IgM is particularly effective when bound to its target, while certain IgG subclasses can also activate the pathway.

The C1 complex consists of three components:

• C1q: Recognizes appropriately positioned antibodies or certain other activating targets.
• C1r: Becomes activated following recognition and activates C1s.
• C1s: An enzyme that cleaves complement components C4 and C2.

Activation of the C1 complex initiates the downstream complement cascade.

2. Cleavage of C4

Activated C1s cleaves complement component C4 into C4a and C4b.

• C4a: Can contribute to inflammatory activity, although its effects are much weaker than those of C3a and C5a.
• C4b: Binds to a nearby suitable surface and provides a platform for the assembly of the next complement components.

Surface attachment of C4b helps localize subsequent reactions near the activating target.

3. Cleavage of C2 and Formation of C3 Convertase

C2 binds to surface-associated C4b and is cleaved by C1s. The resulting C2a fragment remains associated with C4b, producing the classical pathway C3 convertase, C4b2a.

This enzyme complex cleaves complement component C3 into two fragments:

• C3a: Contributes to inflammatory responses.
• C3b: Acts as an opsonin, helping phagocytes recognize and engulf complement-coated targets.

The production of C3b also supports amplification and progression toward the terminal complement pathway.

4. Formation of C5 Convertase

When an additional C3b molecule associates with the classical pathway C3 convertase, the resulting complex functions as C5 convertase, commonly designated C4b2a3b.

C5 convertase cleaves C5 into C5a and C5b.

• C5a: A potent inflammatory mediator and chemoattractant that helps recruit and activate immune cells.
• C5b: Initiates assembly of the terminal complement components.

5. Activation of the Terminal Pathway

C5b sequentially binds C6, C7, and C8, followed by multiple C9 molecules. Together, these components form the membrane attack complex (MAC), which creates a pore in susceptible target membranes.

This pore can disrupt membrane integrity and cause cell lysis, particularly in susceptible microorganisms such as certain Gram-negative bacteria.

6. Biological Importance of the Classical Pathway

The classical pathway contributes to immune defence in several ways:

1. Antibody-assisted recognition: Links antigen-bound antibodies with complement activation.
2. Opsonization: C3b helps phagocytes identify and engulf pathogens.
3. Inflammation: C3a and C5a contribute to inflammatory responses.
4. Immune-complex clearance: Complement fragments help facilitate the removal of antigen–antibody complexes.
5. Terminal complement activation: Initiates the cascade that may result in MAC formation.

In summary, the classical pathway begins with recognition by C1q and proceeds through C4 and C2 cleavage to generate the C3 convertase C4b2a. Subsequent C5 activation and terminal component assembly enable the Complement Pathways to support coordinated immune defence.

Alternative Complement Pathway — Detailed Mechanism

The alternative pathway is an important mechanism of innate immunity that enables complement activation without requiring antibodies. It relies on continuous low-level activation of complement component C3 and the amplification of complement activity on suitable microbial surfaces.

Among the three Complement Pathways, the alternative pathway has a distinctive role because it can initiate complement activity independently of antibody recognition and amplify responses triggered by the classical or lectin pathways.

1. Spontaneous Activation of C3

A small proportion of C3 undergoes spontaneous hydrolysis in plasma through a process known as tick-over. This produces C3(H₂O), which can bind Factor B and support the formation of an initial fluid-phase C3 convertase.

This enzyme cleaves additional C3 molecules, generating C3b. When C3b attaches to a suitable surface, it can initiate the surface-associated alternative pathway.

2. Binding and Cleavage of Factor B

C3b deposited on a surface binds Factor B. Factor D then cleaves the bound Factor B into Ba and Bb.

The Bb fragment remains associated with C3b, forming the alternative pathway C3 convertase:

[
\mathrm{C3bBb}
]

This enzyme cleaves additional C3 into C3a and C3b. Newly generated C3b can attach to suitable surfaces and form more convertase complexes, amplifying the response.

3. Stabilization by Properdin

Properdin (Factor P) stabilizes the C3bBb complex and prolongs its activity. This allows additional C3 molecules to be cleaved and increases complement deposition on susceptible targets.

Amplification is a defining feature of the alternative pathway, but regulatory proteins normally restrict this activity on healthy host surfaces.

4. Formation of C5 Convertase

When an additional C3b molecule associates with the C3 convertase, the resulting complex acts as the alternative pathway C5 convertase:

[
\mathrm{C3bBbC3b}
]

This enzyme cleaves C5 into two fragments:

• C5a: A potent inflammatory mediator that promotes immune-cell recruitment and activation.
• C5b: Initiates assembly of the terminal complement components.

C5b then recruits C6, C7, C8, and multiple C9 molecules to form the membrane attack complex (MAC).

5. Regulation of the Alternative Pathway

The alternative pathway must be tightly controlled to prevent damage to healthy cells. Several regulatory proteins limit activation:

• Factor H: Binds C3b and helps regulate the pathway, particularly on host surfaces.
• Factor I: Inactivates C3b with appropriate cofactors, reducing further convertase formation.
• CD55 (DAF): Accelerates the decay of complement convertases on cell surfaces.
• Properdin: In contrast to these inhibitors, it stabilizes the alternative pathway C3 convertase and promotes amplification.

The balance between activation and regulation allows complement to respond to pathogens while protecting host tissues.

6. Biological Importance

The alternative pathway performs several important functions:

1. Antibody-independent defence: Allows complement activation without antibody recognition.
2. Amplification: Strengthens complement activation initiated by all three pathways.
3. Opsonization: C3b and related fragments help phagocytes recognize pathogens.
4. Inflammation: C3a and C5a contribute to inflammatory responses.
5. Terminal complement activation: Contributes to MAC formation and the destruction of susceptible microorganisms.

The alternative pathway is therefore both an activation route in its own right and an important amplification mechanism within the Complement Pathways. Its effectiveness depends on the interaction between C3 activation, surface deposition, convertase formation, and regulatory control.

Lectin Complement Pathway — Detailed Mechanism

The lectin pathway is an antibody-independent route of complement activation that belongs to the innate immune system. It begins when soluble recognition proteins bind to characteristic molecular patterns on the surfaces of microorganisms. This recognition initiates an enzymatic cascade that ultimately promotes opsonization, inflammation, and terminal complement activation.

Among the three Complement Pathways, the lectin pathway is distinctive because it recognizes microbial surface patterns directly rather than usually relying on antigen-bound antibodies.

1. Recognition of Microbial Surface Patterns

The lectin pathway begins when recognition molecules bind to specific structures on microbial surfaces.

The major recognition molecules include:

• Mannose-binding lectin (MBL): Recognizes particular carbohydrate arrangements, including mannose-rich patterns on certain microorganisms.
• Ficolins: Recognize selected acetylated and other molecular patterns associated with microbial surfaces.

These proteins help the immune system identify potential pathogens without requiring prior antibody production.

2. Activation of MASPs

Mannose-binding lectin and ficolins are associated with enzymes called MBL-associated serine proteases (MASPs). The most important proteases for initiating the downstream complement cascade are MASP-1 and MASP-2.

Following target recognition, these proteases become activated and facilitate the cleavage of complement components C4 and C2. This initiates the next stage of the pathway.

3. Cleavage of C4 and C2

Activated MASPs cleave C4 into C4a and C4b. C4b attaches to a nearby suitable surface and binds C2, which is then cleaved.

The resulting complex, C4b2a, functions as the C3 convertase of the lectin pathway. It is the same C3 convertase formed by the classical pathway.

This enzyme cleaves C3 into:

• C3a: Contributes to inflammatory responses.
• C3b: Promotes opsonization and helps amplify complement activity.

4. Formation of C5 Convertase

Additional C3b associates with the C3 convertase to form the lectin pathway C5 convertase, commonly designated C4b2a3b.

This enzyme cleaves C5 into C5a and C5b.

• C5a: Promotes inflammation and acts as a potent chemoattractant for immune cells.
• C5b: Initiates assembly of the terminal complement components.

C5b then associates sequentially with C6, C7, C8, and multiple C9 molecules to form the membrane attack complex (MAC).

5. Functions of the Lectin Pathway

The lectin pathway contributes to immune defence in several ways:

1. Recognition of pathogens: Detects characteristic molecular patterns on microbial surfaces.
2. Opsonization: C3b and related fragments help phagocytes identify and engulf pathogens.
3. Inflammation: C3a and C5a contribute to inflammatory responses.
4. Amplification of complement activity: Activates the shared downstream complement cascade.
5. Terminal pathway activation: Contributes to MAC formation and the destruction of susceptible microorganisms.

6. Regulation of the Lectin Pathway

The lectin pathway is regulated by proteins that prevent excessive complement activation. C1 inhibitor, for example, inhibits MASP-1 and MASP-2 and helps control pathway initiation. Additional regulatory proteins act on downstream complement components and convertases.

Effective regulation helps the immune system respond to pathogens without causing unnecessary damage to healthy tissues.

In summary, the lectin pathway recognizes microbial molecular patterns through MBL or ficolins, activates associated proteases, and generates the C3 convertase C4b2a. Its downstream reactions are shared with the classical pathway, making it an important part of the coordinated Complement Pathways.

Formation of C3 and C5 Convertases

C3 and C5 convertases are essential enzyme complexes in the complement system. They cleave complement proteins into biologically active fragments, enabling opsonization, inflammation, and activation of the terminal complement pathway.

Although the three Complement Pathways begin through different recognition mechanisms, they generate C3 and C5 convertases that perform comparable functions.

1. What Is a C3 Convertase?

A C3 convertase is an enzyme complex that cleaves complement component C3 into C3a and C3b.

• C3a: Contributes to inflammation by promoting inflammatory mediator release and other immune responses.
• C3b: Binds to microbial surfaces, promotes opsonization, and participates in the formation of C5 convertases.

C3 convertase formation is a central step because it amplifies complement activation by allowing each enzyme complex to cleave multiple C3 molecules.

2. Types of C3 Convertases

There are two principal forms of C3 convertase in the complement system.

A. C3 convertase of the classical and lectin pathways

The classical and lectin pathways produce the same C3 convertase:

C4b2a

Formation occurs through the following steps:

1. C4 is cleaved, producing C4b.
2. C4b attaches to a suitable surface.
3. C2 binds to C4b and is cleaved.
4. The resulting C2a fragment remains associated with C4b, forming C4b2a.

This complex cleaves C3 into C3a and C3b.

B. C3 convertase of the alternative pathway

The alternative pathway produces a different C3 convertase:

C3bBb

Formation occurs as follows:

1. C3 undergoes spontaneous low-level hydrolysis, initiating alternative pathway activity.
2. Factor B binds to C3b or hydrolysed C3.
3. Factor D cleaves the bound Factor B.
4. The Bb fragment remains associated with C3b, producing C3bBb.

Properdin can stabilize C3bBb, prolonging its activity. The complex cleaves additional C3 and supports amplification of complement activation.

3. What Is a C5 Convertase?

A C5 convertase is an enzyme complex that cleaves complement component C5 into C5a and C5b.

• C5a: A potent inflammatory mediator and chemoattractant that helps recruit immune cells to sites of infection.
• C5b: Initiates assembly of the membrane attack complex (MAC).

C5 convertases form when an additional C3b molecule associates with an existing C3 convertase.

4. Types of C5 Convertases

A. C5 convertase of the classical and lectin pathways

The C5 convertase is:

C4b2a3b

It forms when an additional C3b molecule associates with C4b2a. The resulting complex cleaves C5 into C5a and C5b.

B. C5 convertase of the alternative pathway

The C5 convertase is:

C3bBbC3b

It forms when an additional C3b molecule associates with C3bBb. This complex also cleaves C5 and initiates the terminal complement pathway.

5. Comparison of C3 and C5 Convertases

6. Biological Importance

The formation of convertases connects complement recognition to its major defensive effects. C3 convertases generate C3b, which coats pathogens and supports further complement activation. C5 convertases generate C5b, which initiates MAC assembly, while C3a and C5a contribute to inflammatory responses.

The alternative pathway can also amplify C3b deposited through the classical or lectin pathways. Thus, the three Complement Pathways are distinct at initiation but cooperate in producing a coordinated immune response.

Convergence of the Three Complement Pathways

The classical, alternative, and lectin pathways begin through different mechanisms, but they converge on a common sequence of complement reactions. This convergence allows the immune system to recognize different types of threats while producing coordinated defensive responses.

The three Complement Pathways converge at C3 activation and share the downstream reactions that lead to inflammation, opsonization, and formation of the membrane attack complex (MAC).

1. Convergence at C3 Activation

The first major point of convergence is the cleavage of complement component C3.

• The classical pathway forms the C3 convertase C4b2a.
• The lectin pathway also forms the C3 convertase C4b2a.
• The alternative pathway forms the C3 convertase C3bBb.

These enzyme complexes cleave C3 into C3a and C3b.

C3a contributes to inflammation, while C3b attaches to suitable surfaces, promotes opsonization, and helps form C5 convertases. C3b can also support amplification through the alternative pathway.

2. Formation of C5 Convertase

The second major point of convergence is C5 activation.

An additional C3b molecule associates with each pathway’s C3 convertase to form a C5 convertase:

• Classical pathway: C4b2a3b
• Lectin pathway: C4b2a3b
• Alternative pathway: C3bBbC3b

These complexes cleave C5 into C5a and C5b.

C5a is a powerful inflammatory mediator that promotes immune-cell recruitment. C5b initiates assembly of the terminal complement components.

3. Activation of the Terminal Complement Pathway

After C5 cleavage, all three pathways feed into the same terminal sequence.

1. C5b binds C6 to form C5b6.
2. C7 joins the complex, producing C5b-7.
3. C5b-7 associates with the target membrane.
4. C8 binds, followed by polymerization of multiple C9 molecules.
5. These components form the membrane attack complex (MAC), C5b-9.

The MAC forms a pore in susceptible target membranes, which can lead to cell damage and lysis. Its effectiveness varies with the target organism and membrane properties.

4. Major Outcomes of Convergence

The shared downstream reactions produce three major defensive effects.

Opsonization: C3b and its breakdown products coat microbial surfaces, making pathogens easier for phagocytes to recognize and engulf.

Inflammation: C3a and especially C5a promote inflammatory responses. C5a also attracts and activates immune cells.

Direct membrane damage: MAC assembly can disrupt susceptible microbial membranes and cause lysis.

Together, these outcomes help contain infections and coordinate innate immune defence.

5. Role of the Alternative Pathway in Amplification

Although the alternative pathway can initiate complement activation independently, it also serves as an important amplification mechanism. C3b deposited through the classical or lectin pathway can participate in alternative pathway reactions, generating additional C3b and strengthening the response.

This amplification is carefully controlled by regulatory proteins such as Factor H, Factor I, CD55, and CD59, which help limit complement activity and protect host tissues.

6. Summary of the Convergence Process

The overall sequence can be summarized as:

Classical, lectin, or alternative pathway activation → C3 convertase formation → C3 cleavage → C5 convertase formation → C5 cleavage → terminal pathway activation → MAC formation.

Thus, the three Complement Pathways provide different ways to detect threats but share a common effector system that supports pathogen clearance and immune defence.

Comparison of the Three Complement Pathways

The complement system has three major activation pathways: classical, alternative, and lectin. Although each pathway begins differently, all three activate C3, contribute to C5 activation, and can initiate the terminal complement pathway.

Understanding their similarities and differences is important for learning how innate and adaptive immunity work together.

1. Comparison Table

Note: The convertase notation shown here follows the commonly used convention in which C2a is the larger fragment associated with C4b. Classical pathway activation is commonly triggered by antibodies bound to antigens, but certain other ligands can also activate it.

2. Major Similarities

The three pathways share several important features:

• Complement activation: Each pathway initiates a cascade of enzymatic reactions.
• C3 cleavage: Each generates a C3 convertase that cleaves C3 into C3a and C3b.
• C5 cleavage: Each can form a C5 convertase that generates C5a and C5b.
• Inflammation: C3a and C5a contribute to inflammatory responses.
• Opsonization: C3b and its derivatives support pathogen recognition and phagocytosis.
• Terminal pathway activation: Each can lead to MAC formation and lysis of susceptible target cells.

These shared reactions allow the complement system to respond through different recognition mechanisms while producing similar defensive outcomes.

3. Major Differences

The most important difference lies in how each pathway recognizes a potential threat.

Classical pathway: Usually begins when C1q recognizes antibodies bound to an antigen. It therefore provides an important link between adaptive immunity and complement-mediated defence.

Alternative pathway: Can begin through spontaneous low-level C3 hydrolysis and becomes amplified when complement activation is sustained on suitable surfaces. It also amplifies C3b deposited by the other pathways.

Lectin pathway: Begins when MBL or ficolins recognize characteristic molecular patterns on microbial surfaces. It activates MASPs and does not require antibodies.

4. Key Differences

Remember these three associations:

• Classical pathway — C1 complex and antibody-associated activation
• Alternative pathway — Factors B and D, with C3bBb as the C3 convertase
• Lectin pathway — MBL or ficolins and MASPs

For all three pathways, the common outcomes include C3 activation, inflammatory mediator production, opsonization, and potential MAC formation.

In conclusion, the three Complement Pathways differ mainly in their initiation and recognition mechanisms. Their shared downstream reactions enable a coordinated immune response against invading microorganisms.

Biological and Clinical Significance of Complement Pathways

The complement system is an essential part of immune defence. Its three activation pathways help recognize microorganisms, promote their elimination, and coordinate inflammation. Abnormal complement activity, however, can contribute to tissue injury, inflammatory disorders, and susceptibility to certain infections.

Understanding the biological and clinical importance of the Complement Pathways helps explain their roles in normal immunity, disease development, and modern medical treatment.

1. Protection Against Microbial Infections

Complement proteins contribute to the defence against bacteria, viruses, fungi, and other pathogens. The classical, alternative, and lectin pathways recognize different triggers but activate shared downstream mechanisms.

The complement system protects the body by:

• Coating pathogens with complement fragments to facilitate phagocytosis.
• Promoting inflammatory responses that recruit immune cells.
• Forming the membrane attack complex against susceptible microorganisms.
• Amplifying complement activation at sites of infection.

The relative importance of each mechanism depends on the microorganism and the surrounding immune response.

2. Opsonization and Phagocytosis

Opsonization is the process by which a pathogen becomes marked for recognition and engulfment by phagocytic cells.

C3b attaches to microbial surfaces and can be processed into fragments such as iC3b. Phagocytes express complement receptors that recognize these fragments, improving the uptake and removal of pathogens.

This process is particularly important in defence against certain encapsulated bacteria, which can otherwise resist phagocytosis.

3. Inflammation and Immune-Cell Recruitment

Complement activation generates C3a and C5a, which are known as anaphylatoxins.

• C3a: Contributes to inflammatory signalling and can promote mast-cell mediator release.
• C5a: Is a potent chemoattractant and inflammatory mediator that recruits and activates immune cells, particularly neutrophils.

These mediators help coordinate the immune response. Excessive production, however, can contribute to inflammation and damage surrounding tissues.

4. Formation of the Membrane Attack Complex

The terminal complement pathway produces the membrane attack complex (MAC), composed of C5b, C6, C7, C8, and multiple C9 molecules.

The MAC forms pores in susceptible target membranes and can cause cell lysis. It is particularly important in defence against certain Gram-negative bacteria, including Neisseria species.

Host cells are protected by complement regulatory mechanisms. For example, CD59 inhibits the terminal assembly of the MAC on host membranes.

5. Role in the Clearance of Immune Complexes

Immune complexes consist of antigens bound to antibodies. Complement activation can help mark these complexes for transport and removal, reducing the risk of their harmful accumulation in tissues.

C3b and its derivatives interact with complement receptors on immune cells. In humans, complement receptor 1 (CR1) on erythrocytes helps transport immune complexes to the liver and spleen, where they can be removed by phagocytic cells.

Defects in complement-mediated clearance can contribute to immune-complex-associated disease.

6. Clinical Disorders Associated with Complement Deficiency

Inherited or acquired deficiencies in complement proteins can increase susceptibility to infection or contribute to immune dysregulation.

The clinical consequences depend on the particular protein affected, the degree of functional loss, and other genetic or environmental factors.

7. Complement Dysregulation and Disease

Complement activation must be tightly controlled to prevent injury to healthy tissues. When regulation fails, complement activity can contribute to several disorders.

Examples include:

• Atypical haemolytic uraemic syndrome (aHUS): Often associated with dysregulation of the alternative pathway, causing thrombotic microangiopathy.
• Paroxysmal nocturnal haemoglobinuria (PNH): Loss of protective surface proteins, including CD55 and CD59, makes red blood cells vulnerable to complement-mediated destruction.
• Systemic lupus erythematosus (SLE): Deficiencies in certain early classical pathway components are associated with increased susceptibility to lupus, while complement activation can also participate in disease-related inflammation.
• Complement-mediated inflammatory injury: Excessive activation may worsen tissue damage in particular diseases.

These examples illustrate that complement is protective when appropriately activated and regulated, but potentially harmful when its activity becomes uncontrolled.

8. Therapeutic Applications

Complement proteins and regulatory mechanisms are targets for treatments used in selected disorders.

Examples include:

• C5 inhibitors: Eculizumab and ravulizumab block C5 activation and are used in conditions including PNH and aHUS.
• C3 inhibition: Pegcetacoplan inhibits C3 and is used for selected complement-mediated diseases, including PNH.
• Classical pathway inhibition: Sutimlimab targets C1s and is used to treat cold agglutinin disease.

These medicines have specific indications and risks. Blocking complement can increase susceptibility to certain infections, so appropriate vaccination and other preventive measures may be required according to clinical guidance.

9. Importance in Immunology

The study of complement activation helps explain how innate and adaptive immunity cooperate. The classical pathway connects antibody responses with complement activation, while the alternative and lectin pathways provide antibody-independent mechanisms of recognition and defence.

Conclusion

The complement system is an essential component of immune defence that helps the body recognize and eliminate invading microorganisms. Its three activation routes—the classical, alternative, and lectin pathways—differ in their initiating mechanisms but converge on the cleavage of C3 and C5, leading to opsonization, inflammation, and potential formation of the membrane attack complex.

Understanding the Complement Pathways is important for explaining how innate and adaptive immunity cooperate to protect the body. The classical pathway commonly connects antibody responses with complement activation, whereas the alternative and lectin pathways provide antibody-independent mechanisms of recognition and amplification.

Proper regulation of complement activity is equally important because excessive activation can damage healthy tissues. Therefore, complement proteins are significant not only in normal immune defence but also in the diagnosis and treatment of several immune-related disorders.

In summary, the complement system provides a coordinated and tightly regulated mechanism for pathogen recognition, inflammatory signalling, and microbial elimination.

References

1. Merle, N. S., Church, S. E., Fremeaux-Bacchi, V., & Roumenina, L. T. (2015). Complement System Part I — Molecular Mechanisms of Activation and Regulation. Frontiers in Immunology, 6, 262.
   https://doi.org/10.3389/fimmu.2015.00262
2. Merle, N. S., Noe, R., Halbwachs-Mecarelli, L., Fremeaux-Bacchi, V., & Roumenina, L. T. (2015). Complement System Part II: Role in Immunity. Frontiers in Immunology, 6, 257.
   https://doi.org/10.3389/fimmu.2015.00257
3. Ricklin, D., Hajishengallis, G., Yang, K., & Lambris, J. D. (2010). Complement: A Key System for Immune Surveillance and Homeostasis. Nature Immunology, 11, 785–797.
   https://doi.org/10.1038/ni.1923
4. Abbas, A. K., Lichtman, A. H., & Pillai, S. Cellular and Molecular Immunology. Elsevier.
   Publisher website: https://www.elsevier.com/
5. Murphy, K., Weaver, C., & Berg, L. Janeway’s Immunobiology. W. W. Norton & Company.
   Publisher website: https://wwnorton.com/
6. National Library of Medicine. Complement System — Medical and Biomedical Literature. PubMed.
   https://pubmed.ncbi.nlm.nih.gov/?term=complement+system+activation+pathways
7. Merck Manual Professional Edition. Overview of the Immune System.
   https://www.merckmanuals.com/professional/immunology-allergic-disorders/biology-of-the-immune-system/overview-of-the-immune-system